Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Wada

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
European Heart Journal. Quality of Care & Clinical Outcomes|April 8, 2020
Comparison of long-term mortality between patients living alone vs. patients living with others with acute coronary syndrome treated with percutaneous coronary intervention: replyMitsuhiro Takeuchi, Manabu Ogita, Hideki Wada, et al.
Journal of Cardiology|February 19, 2024
Outcome after primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction complicated by cardiogenic shockYui Okada Nozaki, Shoichiro Yatsu, Manabu Ogita, et al.
Annals of Vascular Diseases|October 2, 2023
A Case of Floating Aortic Arch Thrombosis in a Patient without ThrombophiliaRyoma Oda, Kan Kajimoto, Atsumi Oishi, et al.
Cardiovascular Diabetology|February 20, 2020
Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up studyTakehiro Funamizu, Hiroshi Iwata, Yuya Nishida, et al.
International Journal of Cancer|July 7, 2022
Low apolipoprotein A1 was associated with increased risk of cancer mortality in patients following percutaneous coronary intervention: A 10-year follow-up studyHiroki Nishiyama, Takehiro Funamizu, Hiroshi Iwata, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|November 22, 2016
Preprocedural High-Sensitivity C-Reactive Protein Predicts Long-Term Outcome of Percutaneous Coronary InterventionHideki Wada, Tomotaka Dohi, Katsumi Miyauchi, et al.
Scientific Reports|March 25, 2022
Dipeptidyl peptidase-4 inhibitors reduced long-term cardiovascular risk in diabetic patients after percutaneous coronary intervention via insulin-like growth factor-1 axisYuichi Chikata, Hiroshi Iwata, Katsutoshi Miyosawa, et al.
Circulation Reports|May 19, 2021
Impact of Prior Stroke on Long-Term Outcomes in Patients With Acute Coronary SyndromeMitsuhiro Takeuchi, Hideki Wada, Manabu Ogita, et al.
Cardiovascular Diabetology. Endocrinology Reports|November 29, 2025
Prognostic impact of proteinuria in diabetic patients without chronic kidney disease undergoing percutaneous coronary interventionSoshi Moriya, Hiroshi Iwata, Yuichi Chikata, et al.
Cardiovascular Diabetology|March 30, 2024
Elevated levels of plasma inactive stromal cell derived factor-1α predict poor long-term outcomes in diabetic patients following percutaneous coronary interventionYuichi Chikata, Hiroshi Iwata, Katsutoshi Miyosawa, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
European Heart Journal. Quality of Care & Clinical Outcomes|April 8, 2020
Comparison of long-term mortality between patients living alone vs. patients living with others with acute coronary syndrome treated with percutaneous coronary intervention: replyMitsuhiro Takeuchi, Manabu Ogita, Hideki Wada, et al.
Journal of Cardiology|February 19, 2024
Outcome after primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction complicated by cardiogenic shockYui Okada Nozaki, Shoichiro Yatsu, Manabu Ogita, et al.
Annals of Vascular Diseases|October 2, 2023
A Case of Floating Aortic Arch Thrombosis in a Patient without ThrombophiliaRyoma Oda, Kan Kajimoto, Atsumi Oishi, et al.
Cardiovascular Diabetology|February 20, 2020
Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up studyTakehiro Funamizu, Hiroshi Iwata, Yuya Nishida, et al.
International Journal of Cancer|July 7, 2022
Low apolipoprotein A1 was associated with increased risk of cancer mortality in patients following percutaneous coronary intervention: A 10-year follow-up studyHiroki Nishiyama, Takehiro Funamizu, Hiroshi Iwata, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|November 22, 2016
Preprocedural High-Sensitivity C-Reactive Protein Predicts Long-Term Outcome of Percutaneous Coronary InterventionHideki Wada, Tomotaka Dohi, Katsumi Miyauchi, et al.
Scientific Reports|March 25, 2022
Dipeptidyl peptidase-4 inhibitors reduced long-term cardiovascular risk in diabetic patients after percutaneous coronary intervention via insulin-like growth factor-1 axisYuichi Chikata, Hiroshi Iwata, Katsutoshi Miyosawa, et al.
Circulation Reports|May 19, 2021
Impact of Prior Stroke on Long-Term Outcomes in Patients With Acute Coronary SyndromeMitsuhiro Takeuchi, Hideki Wada, Manabu Ogita, et al.
Cardiovascular Diabetology. Endocrinology Reports|November 29, 2025
Prognostic impact of proteinuria in diabetic patients without chronic kidney disease undergoing percutaneous coronary interventionSoshi Moriya, Hiroshi Iwata, Yuichi Chikata, et al.
Cardiovascular Diabetology|March 30, 2024
Elevated levels of plasma inactive stromal cell derived factor-1α predict poor long-term outcomes in diabetic patients following percutaneous coronary interventionYuichi Chikata, Hiroshi Iwata, Katsutoshi Miyosawa, et al.
Pageof 9